A “Twist” In Making DNA Means Huge Growth Prospects For This Stock
The synthetic biology company discussed in today’s article is a favorite of ARK Invest CEO Cathie Wood. In fact, it’s the fifth-largest holding in her ARK Genomic Revolution ETF.
Stock Market
Analysts Say This Small-Cap Biopharmaceutical Stock Is A Buy
The small-cap biopharmaceutical stock featured in today’s article is a Buy according to the consensus among analysts, who see upside potential of nearly 200% from current levels.
Why These 2 Biotech Stocks Could Be Must-Owns This May
After a massive rally last year, biotech stocks have underperformed since February of this year. The author of today’s article, however, believes that the selloff… Read More »Why These 2 Biotech Stocks Could Be Must-Owns This May
Promising Drug Candidates And New Approaches To Unmet Medical Needs Give These 2 Biotech Stocks Over 50% Upside Potential
“Investors in biotech stocks need to find targets with positive catalysts on the near- to mid-term horizon, including promising drug candidates and/or novel approaches to unmet medical needs.”
4 Lesser-Known Biotech Stocks To Get To Know
“Keep an open mind and remain objective as you read about lesser-known biotech stocks. You just might add a couple of big winners to your portfolio.”
4 Biotech Penny Stocks To Watch Heading Into May
Which biotech penny stocks are worth watching heading into the month of May?
New Stocks To Watch In Biotech, Tech & More
Companies involved in life sciences (including for COVID-19), home healthcare and cell therapies are among the six new biotech stocks to watch.
How To Play This Biotech Stock Headed For A Breakout (Or Breakdown)
A rectangle pattern has formed for the biotech stock featured in today’s article, and the author advises that “When this pattern is broken, a breakout or breakdown is expected.”
3 Upcoming Biotech Catalysts To Watch
“If you only have enough time to keep up with a handful of biotech catalysts that are on the way soon, these three are well worth your attention.”
Do These 2 Disruptive Small-Cap Biotech Stocks Have The Potential To Be Millionaire Makers?
Regarding the two stocks he highlights, the author of today’s article declares “these two small-caps are both first movers in healthcare sectors that are ripe for disruption, with massive opportunities over the next decade.”